|
Market Closed -
Hong Kong S.E.
16:08:16 16/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 20.40 HKD | +0.49% |
|
-1.73% | -33.07% |
| 09-24 | Medtide Acquires China Land, Property for Peptide CDMO Project | MT |
| 09-24 | Medtide Inc. Announces Resignation of Li Lingmei as Executive Director, Effective September 24, 2026 | CI |
Company Valuation: Medtide Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,884 | 2,466 | - | - |
| Change | - | -36.5% | - | - |
| Enterprise Value (EV) 1 | 3,027 | 1,887 | 1,817 | 1,722 |
| Change | - | -37.64% | -3.71% | -5.27% |
| P/E | - | - | - | - |
| PBR | 2.31x | 1.3x | 1.14x | 0.98x |
| PEG | - | - | - | - |
| Capitalization / Revenue | 6.81x | 4.12x | 3.32x | 2.77x |
| EV / Revenue | 5.31x | 3.15x | 2.45x | 1.93x |
| EV / EBITDA | 12.6x | 8.21x | 5.8x | 4.44x |
| EV / EBIT | 14.2x | 9.17x | 6.53x | 5.06x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 570.1 | 598.6 | 742.3 | 890.7 |
| EBITDA 1 | 240.2 | 229.9 | 313.1 | 387.5 |
| EBIT 1 | 212.4 | 205.9 | 278.3 | 340.2 |
| Net income | - | - | - | - |
| Net Debt 1 | -857.2 | -578.9 | -649 | -744.7 |
| Reference price 2 | 27.39 | 17.39 | 17.39 | 17.39 |
| Nbr of stocks (in thousands) | 141,800 | 141,800 | - | - |
| Announcement Date | 30/3/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.87x | 10.06x | -.--% | 369M | |
| 18.75x | 6.69x | 13.41x | 1.58% | 65B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| -13.23x | 4.78x | -5.79x | -.--% | 22.03B | |
| Average | 21.22x | 24.20x | 12.31x | 0.29% | 37.23B | |
| Weighted average by Cap. | 23.35x | 24.95x | 14.00x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3880 Stock
- Valuation Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
